Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.185 USD | +0.79% | -0.62% | +37.50% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.50% | 387M | |
-3.16% | 102B | |
+1.49% | 96.29B | |
+2.13% | 22.18B | |
-15.59% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.45% | 16.36B | |
+4.96% | 13.97B | |
+32.34% | 12.17B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5